Safety and Immunogenicity of MT-5625 in Healthy Adults, Toddlers and Infants
Clinical trial NCT03507738 · COMPLETED
Trial details
- NCT number
- NCT03507738
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-03
- Primary completion
- 2019-06-28
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.